Ascendis Health Limited (ASC.JO)
ZAc 78.0
(0.0%)
ZAc 78.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 444.57 Million ZAR | 9.02% |
| 2022 | 407.81 Million ZAR | -68.03% |
| 2021 | 1.27 Billion ZAR | -87.39% |
| 2020 | 10.12 Billion ZAR | -7.51% |
| 2019 | 10.94 Billion ZAR | 18.95% |
| 2018 | 9.2 Billion ZAR | 1.29% |
| 2017 | 9.08 Billion ZAR | -1.17% |
| 2016 | 9.19 Billion ZAR | 181.33% |
| 2015 | 3.26 Billion ZAR | 79.15% |
| 2014 | 1.82 Billion ZAR | 35.69% |
| 2013 | 1.34 Billion ZAR | 141.87% |
| 2012 | 555.6 Million ZAR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 479.61 Million ZAR | 17.61% |
| 2023 FY | 444.58 Million ZAR | 9.02% |
| 2023 Q4 | 444.57 Million ZAR | 0.0% |
| 2023 Q3 | 444.57 Million ZAR | -7.3% |
| 2023 Q2 | 479.61 Million ZAR | 0.0% |
| 2022 Q4 | 407.81 Million ZAR | 0.0% |
| 2022 Q2 | 702.94 Million ZAR | 0.0% |
| 2022 Q3 | 407.81 Million ZAR | -41.98% |
| 2022 FY | 407.81 Million ZAR | -68.03% |
| 2022 Q1 | 702.94 Million ZAR | -44.9% |
| 2021 Q1 | 1.33 Billion ZAR | -86.85% |
| 2021 Q2 | 1.33 Billion ZAR | -0.0% |
| 2021 Q3 | 1.27 Billion ZAR | -4.14% |
| 2021 Q4 | 1.27 Billion ZAR | 0.0% |
| 2021 FY | 1.27 Billion ZAR | -87.39% |
| 2020 Q4 | 10.12 Billion ZAR | 0.0% |
| 2020 FY | 10.12 Billion ZAR | -7.51% |
| 2020 Q1 | 10.13 Billion ZAR | -7.37% |
| 2020 Q2 | 10.13 Billion ZAR | 0.0% |
| 2020 Q3 | 10.12 Billion ZAR | -0.16% |
| 2019 FY | 10.94 Billion ZAR | 18.95% |
| 2019 Q1 | 8.88 Billion ZAR | -3.43% |
| 2019 Q2 | 8.88 Billion ZAR | 0.0% |
| 2019 Q3 | 10.82 Billion ZAR | 21.8% |
| 2019 Q4 | 10.94 Billion ZAR | 1.12% |
| 2018 Q1 | 9.07 Billion ZAR | -0.06% |
| 2018 Q4 | 9.2 Billion ZAR | -0.86% |
| 2018 Q3 | 9.28 Billion ZAR | 2.23% |
| 2018 Q2 | 9.07 Billion ZAR | 0.0% |
| 2018 FY | 9.2 Billion ZAR | 1.29% |
| 2017 Q4 | 9.08 Billion ZAR | -0.05% |
| 2017 Q2 | 8.09 Billion ZAR | 0.0% |
| 2017 Q1 | 8.09 Billion ZAR | -11.92% |
| 2017 FY | 9.08 Billion ZAR | -1.17% |
| 2017 Q3 | 9.08 Billion ZAR | 12.26% |
| 2016 FY | 9.19 Billion ZAR | 181.33% |
| 2016 Q2 | 7.1 Billion ZAR | 0.0% |
| 2016 Q3 | 9.24 Billion ZAR | 30.1% |
| 2016 Q4 | 9.19 Billion ZAR | -0.62% |
| 2016 Q1 | 7.1 Billion ZAR | 117.59% |
| 2015 FY | 3.26 Billion ZAR | 79.15% |
| 2015 Q1 | 2.6 Billion ZAR | 42.9% |
| 2015 Q4 | 3.26 Billion ZAR | -0.14% |
| 2015 Q3 | 3.27 Billion ZAR | 25.54% |
| 2015 Q2 | 2.6 Billion ZAR | 0.0% |
| 2014 Q2 | 1.4 Billion ZAR | 0.0% |
| 2014 FY | 1.82 Billion ZAR | 35.69% |
| 2014 Q1 | 1.4 Billion ZAR | 4.91% |
| 2014 Q3 | 1.83 Billion ZAR | 29.86% |
| 2014 Q4 | 1.82 Billion ZAR | -0.4% |
| 2013 Q2 | 928.62 Million ZAR | 0.0% |
| 2013 Q3 | 1.4 Billion ZAR | 50.92% |
| 2013 Q4 | 1.34 Billion ZAR | -4.11% |
| 2013 FY | 1.34 Billion ZAR | 141.87% |
| 2013 Q1 | 928.62 Million ZAR | 67.14% |
| 2012 Q4 | 555.6 Million ZAR | 0.0% |
| 2012 FY | 555.6 Million ZAR | 0.0% |
| 2012 Q1 | - ZAR | 0.0% |
| 2012 Q3 | 555.6 Million ZAR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|